Technology is increasingly being utilized in redesigns of healthcare delivery. What are the promises and pitfalls? In this university podcast, healthcare innovator Andrew Thompson discusses how computer technology, in particular, may be utilized to help us achieve the goal of universal healthcare. He looks at the challenges of reaching that goal in terms of access, value, sustainability, and affordability, as well as what lessons may be applied from other industries. This podcast is from the Stanford Graduate School of Business Future of Healthcare series.
Andrew Thompson is president, CEO and co-founder of Proteus Biomedical. Thompson began his career as an industrial trainee at Metal Box PLC. Later he was a management consultant with Booz Allen & Hamilton specializing in operations management. For the last 20 years he has lived in Silicon Valley and focused on the start-up and development of technology based medical businesses. Companies that have completed successful IPOs or have been acquired by Fortune 100 businesses where he played an important role include: Cell Genesys (NASDAQ IPO), Cytotherapeutics (NASDAQ IPO), Abgenix (NASDAQ IPO), CardioRhythm (acquired by Medtronic), FemRx (NASDAQ IPO, acquired by J&J), Northstar Neuroscience (NASDAQ IPO) and QRx Pharmaceuticals (ASX IPO).
Resources
This free podcast is from our The Future of Health Care series.
For The Conversations Network:
Photo: NY Times